Neuroprotective effect of Mulmina™ against chemotherapy‑induced cognitive decline in normal rats

Kinra, Manas and Ranadive, Niraja and Gourishetti, Karthik and Nayak, Pawan G and Mudgal, Jayesh and Nandakumar, Krishnadas (2021) Neuroprotective effect of Mulmina™ against chemotherapy‑induced cognitive decline in normal rats. Biomedical Reports, 14 (1). pp. 1-7. ISSN 2049-9434

[img] PDF
11255 DisplayPdf.pdf - Published Version
Restricted to Registered users only

Download (616kB) | Request a copy

Abstract

The aim of the present study was to evaluate a marketed formulation against chemotherapy‑induced cognitive dysfunction. The formulation, Mulmina™, contains natural compounds which are known to help in improving function as well as in preventing cognitive decline. All of the phytoconstituents in the formulation have been tested individually but this is the first study where such a formulation has been evaluated against chemotherapy‑induced cognitive decline (CICD) in a mouse model. CICD was induced by cyclophosphamide (50 mg/kg), methotrexate (5 mg/kg), and 5‑fluorouracil (5 mg/kg) (CMF), administered intraperitonially. CMF was administered in three cycles, with one injection per week for three weeks. The decline in cognition of the mice was evaluated by a test of locomotor activity (Open Field Test) followed by a test for spatial memory (Morris Water Maze).Biochemical parameters evaluated include brain cytokine levels and BDNF levels via ELISA. Hematological counts were also performed to evaluate any changes in blood profile using a veterinary blood cell counter. Levels of oxidative stress markers with respect to catalase activity and lipid peroxidation were also evaluated in the brain using UV-spectrophotometric analysis. Mulmina™ was able to show significant improvement in cognitive function post chemotherapy when compared to the untreated animals. Apart from improvement in spatial memory, there was also an improvement in biochemical parameters. The particular combination of phytochemicals in Mulmina™ proved themselves successful in alleviating the CICD in this preliminary study and pave a path for future studies which can establish the solid grounds with respect to molecular and pharmacological basis for the mechanism of action of Mulmina™

Item Type: Article
Uncontrolled Keywords: Chemobrain; Chemotherapy; Cognition; Neuroinflammation; Cytokines
Subjects: Pharmacy > MCOPS Manipal > Pharmacology
Depositing User: KMC Library
Date Deposited: 01 Jun 2021 10:31
Last Modified: 01 Jun 2021 10:31
URI: http://eprints.manipal.edu/id/eprint/156557

Actions (login required)

View Item View Item